Skip to content
Recall Observatory FDA recall evidence

Drug product

Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg, 30-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India; NDC 62756-970-83

D-0024-2023

October 18, 2022

Class II

Product summary

Firm
SUN PHARMACEUTICAL INDUSTRIES INC
Event
Event 91033
Status
Terminated
Classification
Class II
Quantity
N/A
Official record key
drug-enforcement:D-0024-2023

Official wording

Reason: Presence of Foreign Substance

Code information: Lot #: DNC1129A, Exp 06/2023 Lot #: DNC1740A, Exp 09/2023

Distribution pattern: Nationwide with the United States

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Foreign Substance